West End Aesthetics Ltd SC761235 false 2023-03-06 2024-03-31 2024-03-31 The principal activity of the company is aesthetics treatments Digita Accounts Production Advanced 6.30.9574.0 true SC761235 2023-03-06 2024-03-31 SC761235 2024-03-31 SC761235 bus:OrdinaryShareClass1 bus:CumulativeShares 2024-03-31 SC761235 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 SC761235 core:FurnitureFittingsToolsEquipment 2024-03-31 SC761235 bus:SmallEntities 2023-03-06 2024-03-31 SC761235 bus:AuditExemptWithAccountantsReport 2023-03-06 2024-03-31 SC761235 bus:FullAccounts 2023-03-06 2024-03-31 SC761235 bus:SmallCompaniesRegimeForAccounts 2023-03-06 2024-03-31 SC761235 bus:RegisteredOffice 2023-03-06 2024-03-31 SC761235 bus:Director1 2023-03-06 2024-03-31 SC761235 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-03-06 2024-03-31 SC761235 bus:PrivateLimitedCompanyLtd 2023-03-06 2024-03-31 SC761235 core:FurnitureFittingsToolsEquipment 2023-03-06 2024-03-31 SC761235 core:OfficeEquipment 2023-03-06 2024-03-31 SC761235 countries:Scotland 2023-03-06 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: SC761235

West End Aesthetics Ltd

Annual Report and Unaudited Financial Statements

for the Period from 6 March 2023 to 31 March 2024

 

West End Aesthetics Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 5

 

West End Aesthetics Ltd

Company Information

Director

Mrs Nicola Shona McFarland

Registered office

9 Kendal Drive
Kelvindale
Glasgow
G12 0DF

Accountants

Clyde Business Services
159 King Street
Glasgow
Lanarkshire
G73 1BZ

 

West End Aesthetics Ltd

(Registration number: SC761235)
Balance Sheet as at 31 March 2024

Note

2024
£

Fixed assets

 

Tangible assets

4

4,066

Current assets

 

Stocks

5

4,500

Cash at bank and in hand

 

1,995

 

6,495

Creditors: Amounts falling due within one year

6

(12,382)

Net current liabilities

 

(5,887)

Net liabilities

 

(1,821)

Capital and reserves

 

Called up share capital

7

1

Retained earnings

(1,822)

Shareholders' deficit

 

(1,821)

For the financial period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the director on 31 July 2024
 

.........................................
Mrs Nicola Shona McFarland
Director

 

West End Aesthetics Ltd

Notes to the Unaudited Financial Statements for the Period from 6 March 2023 to 31 March 2024

1

General information

The company is a private company limited by share capital, incorporated in Scotland.

The address of its registered office is:
9 Kendal Drive
Kelvindale
Glasgow
G12 0DF

These financial statements were authorised for issue by the director on 31 July 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

equipment

20% reducing balance

 

West End Aesthetics Ltd

Notes to the Unaudited Financial Statements for the Period from 6 March 2023 to 31 March 2024

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

 

West End Aesthetics Ltd

Notes to the Unaudited Financial Statements for the Period from 6 March 2023 to 31 March 2024

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

Additions

4,682

4,682

At 31 March 2024

4,682

4,682

Depreciation

Charge for the period

616

616

At 31 March 2024

616

616

Carrying amount

At 31 March 2024

4,066

4,066

5

Stocks

2024
£

Finished goods and goods for resale

4,500

6

Creditors

Creditors: amounts falling due within one year

2024
£

Due within one year

Other creditors

12,382

7

Share capital

Allotted, called up and fully paid shares

 

2024

 

No.

£

Ordinary of £1 each

1

1